.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Dow
Teva
Mallinckrodt
AstraZeneca
US Department of Justice
Fish and Richardson
Citi
Cerilliant
McKinsey

Generated: November 22, 2017

DrugPatentWatch Database Preview

CLOFIBRATE Drug Profile

« Back to Dashboard

Which patents cover Clofibrate, and when can generic versions of Clofibrate launch?

Clofibrate is a drug marketed by Teva, Watson Labs, Usl Pharma, Sandoz, and Banner Pharmacaps. and is included in five NDAs.

The generic ingredient in CLOFIBRATE is clofibrate. There are four drug master file entries for this compound. Additional details are available on the clofibrate profile page.

Summary for CLOFIBRATE

Medical Subject Heading (MeSH) Categories for CLOFIBRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
CLOFIBRATE
clofibrate
CAPSULE;ORAL072600-001Jul 25, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CLOFIBRATE
clofibrate
CAPSULE;ORAL072191-001May 2, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
CLOFIBRATE
clofibrate
CAPSULE;ORAL071603-001Sep 18, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Usl Pharma
CLOFIBRATE
clofibrate
CAPSULE;ORAL070531-001Jun 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Banner Pharmacaps
CLOFIBRATE
clofibrate
CAPSULE;ORAL073396-001Mar 20, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Moodys
Chinese Patent Office
US Army
US Department of Justice
UBS
McKinsey
Citi
Fuji
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot